Intraventricular conduction delay: a prognostic marker in chronic heart failure

被引:280
|
作者
Shamim, W
Francis, DP
Yousufuddin, M
Varney, S
Pieopli, MF
Anker, SD
Coats, AJS
机构
[1] Royal Brompton Hosp, London 5W3 6NP, England
[2] Natl Heart & Lung Inst, Dept Cardiac Med, London 5W3 6NP, England
关键词
electrocardiography; prognosis; heart failure; mortality; survival;
D O I
10.1016/S0167-5273(99)00077-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic heart failure (CHF) is associated with high mortality, and there are several established clinical and laboratory parameters that predict mortality in CHF. The purpose of this study was (a) to identify the best ECG parameter that predicts mortality, (b) to evaluate the prognostic marker of ECG against well-established indicators of prognosis. Relevant data from 241 CHF patients were analysed retrospectively. Cardiopulmonary exercise testing and radionuclide ventriculogram were also performed where possible. The mean follow-up period was 31 months. On univariate analysis by the Cox proportional Hazard method, intraventricular conduction delay (IVCD) [P<0.0001, hazard ratio 1.017 (1.011-1.024)] and QTc [P<0.0001, hazard ratio 1.012 (1.006-1.017)] were identified as predictors of mortality. On bivariate analysis, IVCD and MVO2 were better predictors when combined together. A model based on multivariate analysis showed that IVCD, MVO2 and left ventricular ejection fraction (LVEF) were the best predictors of mortality. The addition of plasma sodium, age and NYHA class had no added benefit on the predictive power of the model. Further analysis of IVCD and QTc showed that, for different cut-off values, IVCD is better than QTc, and that there is a graded increase in mortality with increasing value of IVCD. We have found that IVCD is an important ECG predictor of prognosis in patients with CHF. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 50 条
  • [1] Microalbuminuria is an independent prognostic marker in patients with chronic heart failure
    Villacorta, Humberto
    Ferradaes, Paula de Vilhena
    Mesquita, Evandro Tinoco
    Lucas da Nobrega, Antonio Claudio
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2012, 98 (01) : 62 - 68
  • [2] Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure
    Cinca, Juan
    Mendez, Ana
    Puig, Teresa
    Ferrero, Andreu
    Roig, Eulalia
    Vazquez, Rafael
    Gonzalez-Juanatey, Jose R.
    Alonso-Pulpon, Luis
    Delgado, Juan
    Brugada, Josep
    Pascual-Figal, Domingo
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (08) : 877 - 884
  • [3] Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction
    Achten, Anouk
    Weerts, Jerremy
    van Koll, Johan
    Ghossein, Mohammed
    Mourmans, Sanne G. J.
    Aizpurua, Arantxa Barandiaran
    van Stipdonk, Antonius M. W.
    Vernooy, Kevin
    Prinzen, Frits W.
    Rocca, Hans-Peter Brunner-La
    Knackstedt, Christian
    van Empel, Vanessa P. M.
    IJC HEART & VASCULATURE, 2025, 57
  • [4] Bioelectrical impedance phase angle as a prognostic marker in chronic heart failure
    Colin-Ramirez, Eloisa
    Castillo-Martinez, Lilia
    Orea-Tejeda, Arturo
    Vazquez-Duran, Marisela
    Rodriguez, Ana E.
    Keirns-Davis, Candace
    NUTRITION, 2012, 28 (09) : 901 - 905
  • [5] Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology
    Zafrir, Barak
    Salman, Nabeeh
    Crespo-Leiro, Maria G.
    Anker, Stefan D.
    Coats, Andrew J.
    Ferrari, Roberto
    Filippatos, Gerasimos
    Maggioni, Aldo P.
    Mebazaa, Alexandre
    Piepoli, Massimo Francesco
    Ruschitzka, Frank
    Paniagua-Martin, Maria J.
    Segovia, Javier
    Laroche, Cecile
    Amir, Offer
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (07) : 859 - 868
  • [6] Relation of intraventricular conduction delay to risk of new-onset heart failure and structural heart disease in the general population
    Rankinen, Jani
    Haataja, Petri
    Lyytikainen, Leo-Pekka
    Huhtala, Heini
    Lehtimaki, Terho
    Kahonen, Mika
    Eskola, Markku
    Perez-Riera, Andres Ricardo
    Jula, Antti
    Niiranen, Teemu
    Nikus, Kjell
    Hernesniemi, Jussi
    IJC HEART & VASCULATURE, 2020, 31
  • [7] Platelet Distribution Width as a Novel Prognostic Marker in Chronic Heart Failure
    Ishino, Mitsunori
    Arimoto, Takanori
    Tamura, Harutoshi
    Netsu, Shunsuke
    Otaki, Yoichiro
    Funayama, Akira
    Hasegawa, Hiromasa
    Honda, Shintaro
    Nishiyama, Satoshi
    Takahashi, Hiroki
    Shishido, Tetsuro
    Miyashita, Takehiko
    Miyamoto, Takuya
    Watanabe, Tetsu
    Kubota, Isao
    CIRCULATION, 2011, 124 (21)
  • [8] Neopterin as a prognostic marker in patients with chronic heart failure
    Wietlicka-Kokoszanek, Irmina
    Jablecka, Anna
    Smolarek, Iwona
    Bogdanski, Pawel
    Chmara, Ewa
    Korzeniowska, Katarzyna
    Kazmierczak, Miroslaw
    Kazmierczak, Ewa
    Musialik, Katarzyna
    MEDICAL SCIENCE MONITOR, 2010, 16 (05): : CR232 - CR237
  • [9] Cardiac resynchronisation therapy for chronic heart failure and conduction delay
    Cubbon, Richard M.
    Witte, Klaus K. A.
    BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 : 1064 - 1069
  • [10] Inflammation as a Prognostic Marker in Heart Failure
    Lima, Priscila C.
    Rios, Davi M.
    de Oliveira, Filipe P.
    Passos, Larissa R.
    Ribeiro, Ludmila B.
    Serpa, Renato G.
    Calil, Osmar A.
    de Barros, Lucas C.
    Barbosa, Luiz Fernando M.
    Barbosa, Roberto R.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)